Nephrology News

New Drug Slows Advanced Kidney Cancer
Treating advanced kidney cancer patients with the drug pazopanib (Votrient) slowed their disease progression by 54 percent, a new study has found.The phase 3 study included 233 patients with previously untreated kidney cancer (also known as renal cell carcinoma) that was locally advanced or had spread, and 202 patients with renal cell carcinoma who had previously been treated with cytokine therapy (interferon or interleukin). The patients were randomly assigned to take pazopanib tablets (290 patients) or a placebo drug (145 patients).

Bypass Anemia Drugs in Chronic Kidney Disease, Expert Says
Anemia in most chronic kidney disease patients should be managed with iron supplements or blood transfusions, if anything, rather than erythrocyte-stimulating agents, a leading nephrologist has recommended. The only good case for long-term use of erythropoietin drugs in this population is in those who are transplant candidates or have severe anemia with a hemoglobin under 9 g/dl that cannot be managed with transfusions, Ajay K. Singh, of Harvard and Brigham and Women's Hospital in Boston, concluded.

Hospital Re-Admission High For Dialysis Patients Treated In Long-Term Care Hospitals
A new study by University of Cincinnati (UC) nephrologists shows that most dialysis patients admitted to long-term care hospitals face readmission to acute care facilities, and those with acute kidney failure don't often recover full kidney function. This study is being published in the advanced online edition of the American Journal of Kidney Diseases, the official journal of the National Kidney Foundation.

More News

• Effect of a Low- Versus Moderate-Protein Diet on Progression of CKD
• Revascularization shows no difference than medical therapy for renal artery stenosis
• Recurrent Lupus Nephritis in Kidney Transplant Recipients With SLE Can Be Predicted
• For People on Dialysis, Too Thin Can Be Risky
• Noncardiovascular Mortality Among Patients Starting Dialysis Bests Cardiovascular Mortality
• Kidney function is associated with the rate of cognitive decline in the elderly
  
  • Neurology
• Trace elements in end-stage renal disease – unfamiliar territory to be revealed
  
• Lab Test Predicts Acute Kidney Injury in ICU Patients
  
• Lower Level of Target Hemoglobin More Beneficial In Patients with Chronic Kidney Disease
  
  • Archives of Internal Medicine Abstract
• Chronic Kidney Disease Raises Risk for Some Cancers
  
• Hyperuricemia appears to be an independent risk factor for all-cause and CVD mortality, but not kidney failure
  • American Journal of Kidney Diseases
• Statins offer no cardiovascular protection for patients with end-stage renal disease on hemodialysis
• Impaired Tubular Uptake Explains Albuminuria in Early Diabetic Nephropathy
  
  • Journal of the American Society of Nephrology
• Proteinuria An Independant Risk Factor For Stroke
  
• What should we expect from optimal dialsyis?
• Use of hemodialysis and hemoperfusion in poisoned patients
  
• Proteinuria strongly associated with CHD risk
  
• Little-known E. coli strain O111 Starts Gaining Notoriety
  
• Hyperuricemia an independent predicor of kidney disease
  
• Obesity, smoking, and physical inactivity as risk factors for CKD: Are men more vulnerable?